{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:01:33Z","timestamp":1776250893349,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-025-09352-x","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:56:32Z","timestamp":1764320192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nodular amyloid deposits with collagen fibre rupture in tenosynovial carpal tissues are associated with transthyretin cardiomyopathy: a single-centre prospective diagnostic study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jozef","family":"Zustin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Plenagl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Saracel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Karczmarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schreck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Luchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Spies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"9352_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1186\/s12891-023-06853-5","volume":"24","author":"E Aldinc","year":"2023","unstructured":"Aldinc E, Campbell C, Gustafsson F, Beveridge A, Macey R, Marr L, et al. Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review. BMC Musculoskelet Disord. 2023;24:751 PMID: 37740174.","journal-title":"BMC Musculoskelet Disord"},{"key":"9352_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.13169","volume":"289","author":"E Muchtar","year":"2021","unstructured":"Muchtar E, Dispenzieri A, Magen H, Grogan M, Mauermann M, McPhail ED, et al. Systemic amyloidosis from a (AA) to t (ATTR): a review. J Intern Med. 2021;289:268\u201392 PMID: 32929754.","journal-title":"J Intern Med"},{"key":"9352_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506129.2022.2091985","volume":"30","author":"D Adams","year":"2023","unstructured":"Adams D, Tournev IL, Taylor MS, Coelho T, Plant\u00e9-Bordeneuve V, Berk JL, et al. Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial. Amyloid. 2023;30:1\u20139 PMID: 35875890.","journal-title":"Amyloid"},{"key":"9352_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1474-4422(20)30368-9","volume":"20","author":"D Adams","year":"2021","unstructured":"Adams D, Polydefkis M, Gonz\u00e1lez-Duarte A, Wixner J, Kristen AV, Schmidt HH, et al. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 2021;20:49\u201359.","journal-title":"Lancet Neurol"},{"key":"9352_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2047-9158-3-19","volume":"3","author":"M Ueda","year":"2014","unstructured":"Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener. 2014;3:19 PMID: 25228988.","journal-title":"Transl Neurodegener"},{"key":"9352_CR6","doi-asserted-by":"publisher","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, et al. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail. 2019;12:e006075 PMID: 31480867.","journal-title":"Circ Heart Fail"},{"key":"9352_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","volume":"27","author":"JN Nativi-Nicolau","year":"2022","unstructured":"Nativi-Nicolau JN, Karam C, Khella S, Maurer MS. Screening for ATTR amyloidosis in the clinic: overlapping disorders and misdiagnosis. Heart Fail Rev. 2022;27:785\u201393 PMID: 33609196.","journal-title":"Heart Fail Rev"},{"key":"9352_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s00415-019-09671-9","volume":"267","author":"T Coelho","year":"2020","unstructured":"Coelho T, Yarlas A, Waddington-Cruz M, White MK, Kessler AS, Lovley A, et al. Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis with polyneuropathy. J Neurol. 2020;267:1070\u20139 PMID: 31853709.","journal-title":"J Neurol"},{"key":"9352_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang CC, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379:11\u201321 PMID: 29972753.","journal-title":"N Engl J Med"},{"key":"9352_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jhsa.2019.06.016","volume":"44","author":"JP Donnelly","year":"2019","unstructured":"Donnelly JP, Hanna M, Sperry BW, Seitz WH Jr. Carpal tunnel syndrome: a potential early, red-flag sign of amyloidosis. J Hand Surg Am. 2019;44:868\u201376 PMID: 31400950.","journal-title":"J Hand Surg Am"},{"key":"9352_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/jfmpc.jfmpc_510_15","volume":"7","author":"RPJC Ramanayake","year":"2018","unstructured":"Ramanayake RPJC, Basnayake BMTK. Evaluation of red flags minimizes missing serious diseases in primary care. J Family Med Prim Care. 2018;7:315\u20138 PMID: 30090770.","journal-title":"J Family Med Prim Care"},{"key":"9352_CR12","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","volume":"72","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, et al. Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J Am Coll Cardiol. 2018;72:2040\u201350 PMID: 30336828.","journal-title":"J Am Coll Cardiol"},{"key":"9352_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5334\/gh.1262","volume":"18","author":"D Brito","year":"2023","unstructured":"Brito D, Albrecht FC, de Arenaza DP, Bart N, Better N, Carvajal-Juarez I, et al. World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). Glob Heart. 2023;18:59 PMID: 37901600.","journal-title":"Glob Heart"},{"key":"9352_CR14","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","volume":"108","author":"F AusdemSiepen","year":"2019","unstructured":"AusdemSiepen F, Hein S, Prestel S, Baumg\u00e4rtner C, Sch\u00f6nland S, Hegenbart U, et al. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Clin Res Cardiol. 2019;108:1324\u201330 PMID: 30953182.","journal-title":"Clin Res Cardiol."},{"key":"9352_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/jcm13030671","volume":"13","author":"AM Jakstaite","year":"2024","unstructured":"Jakstaite AM, Vogel JK, Luedike P, J\u00e1nosi RA, Carpinteiro A, Rischpler C, et al. Screening for occult transthyretin amyloidosis in patients with severe aortic stenosis and amyloid red flags. J Clin Med. 2024;13:671 PMID: 38337363.","journal-title":"J Clin Med"},{"issue":"102","key":"9352_CR16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jhsa.2024.09.010","volume":"50","author":"AM Gray","year":"2025","unstructured":"Gray AM, Patel AC, Kaplan FTD, Merrell GA, Greenberg JA. Occult amyloid deposition in older patients presenting with bilateral carpal tunnel syndrome or multiple trigger digits. J Hand Surg Am. 2025;50(102):e1-6 PMID: 37354196.","journal-title":"J Hand Surg Am"},{"key":"9352_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/a-0747-6096","volume":"50","author":"K Hahn","year":"2018","unstructured":"Hahn K, Urban P, Meli\u00df RR, Axmann HD, Siebert F, R\u00f6cken C. Carpal tunnel syndrome and ATTR-amyloidosis. Handchir Mikrochir Plast Chir. 2018;50:329\u201334 PMID: 30404120. [Article in German].","journal-title":"Handchir Mikrochir Plast Chir."},{"key":"9352_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/13506129.2017.1316711","volume":"24","author":"K Hahn","year":"2017","unstructured":"Hahn K, Nilsson KPR, Hammarstr\u00f6m P, Urban P, Meliss RR, Behrens HM, et al. Establishing and validating the fluorescent amyloid ligand h-FTAA (heptamer formyl thiophene acetic acid) to identify transthyretin amyloid deposits in carpal tunnel syndrome. Amyloid. 2017;24:78\u201386 PMID: 28434259.","journal-title":"Amyloid"},{"key":"9352_CR19","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1097\/00006534-200004050-00010","volume":"105","author":"MJ Concannon","year":"2000","unstructured":"Concannon MJ, Brownfield ML, Puckett CL. The incidence of recurrence after endoscopic carpal tunnel release. Plast Reconstr Surg. 2000;105:1662\u20135 PMID: 10809095.","journal-title":"Plast Reconstr Surg"},{"key":"9352_CR20","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2106\/00004623-199311000-00002","volume":"75","author":"DW Levine","year":"1993","unstructured":"Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, et al. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am. 1993;75:1585\u201392 PMID: 8245050.","journal-title":"J Bone Joint Surg Am"},{"key":"9352_CR21","first-page":"167","volume":"44","author":"DH Palmer","year":"1995","unstructured":"Palmer DH, Hanrahan LP. Social and economic costs of carpal tunnel surgery. Instr Course Lect. 1995;44:167\u201372 PMID: 7797856.","journal-title":"Instr Course Lect"},{"key":"9352_CR22","first-page":"72","volume":"54","author":"S Breda","year":"1993","unstructured":"Breda S, Richter HP, Schachenmayr W. Incidence of biopsy-detectable amyloid deposits in the retinaculum flexorum and tenosynovial tissue in carpal tunnel syndrome. Zentralbl Neurochir. 1993;54:72\u20136 PMID: 8368037.","journal-title":"Zentralbl Neurochir"},{"key":"9352_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13506129.2012.750604","volume":"20","author":"Z Gioeva","year":"2013","unstructured":"Gioeva Z, Urban P, Meliss RR, Haag J, Axmann HD, Siebert F, et al. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome. Amyloid. 2013;20:1\u20136 PMID: 23244293.","journal-title":"Amyloid"},{"key":"9352_CR24","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.humpath.2010.11.017","volume":"42","author":"T Sueyoshi","year":"2011","unstructured":"Sueyoshi T, Ueda M, Jono H, Irie H, Sei A, Ide J, et al. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol. 2011;42:1259\u201364 PMID: 21334722.","journal-title":"Hum Pathol"},{"key":"9352_CR25","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1093\/eurjpc\/zwab127","volume":"29","author":"M Merlo","year":"2022","unstructured":"Merlo M, Porcari A, Pagura L, Cameli M, Vergaro G, Musumeci B, et al. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study. Eur J Prev Cardiol. 2022;29:e173\u20137 PMID: 34499711.","journal-title":"Eur J Prev Cardiol"},{"key":"9352_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233\u201370 PMID: 25712077.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9352_CR27","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s11845-021-02832-8","volume":"191","author":"HC B\u00e4cker","year":"2022","unstructured":"B\u00e4cker HC, Galle SE, Lentzsch S, Freibott CE, Shoap S, Strauch RJ, et al. Flexor tenosynovectomy in carpal tunnel syndrome as a screening tool for early diagnosis of amyloidosis. Ir J Med Sci. 2022;191:2427\u201330 PMID: 34709577.","journal-title":"Ir J Med Sci"},{"key":"9352_CR28","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/(SICI)1097-4598(199610)19:10<1349::AID-MUS16>3.0.CO;2-P","volume":"19","author":"KI Nakamichi","year":"1996","unstructured":"Nakamichi KI, Tachibana S. Amyloid deposition in the synovium and ligament in idiopathic carpal tunnel syndrome. Muscle Nerve. 1996;19:1349\u201351 PMID: 8808665.","journal-title":"Muscle Nerve"},{"key":"9352_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00750729","volume":"412","author":"K Stein","year":"1987","unstructured":"Stein K, St\u00f6rkel S, Linke RP, Goebel HH. Chemical heterogeneity of amyloid in the carpal tunnel syndrome. Virchows Arch A Pathol Anat Histopathol. 1987;412:37\u201345 PMID: 3120402.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"9352_CR30","doi-asserted-by":"publisher","first-page":"101086","DOI":"10.1016\/j.jacadv.2024.101086","volume":"3","author":"N Mora-Ayestaran","year":"2024","unstructured":"Mora-Ayestaran N, Dispenzieri A, Kristen AV, Maurer MS, Diemberger I, Drachman BM, et al. Age- and sex-related differences in patients with wild-type transthyretin amyloidosis: insights from THAOS. JACC Adv. 2024;3:101086 PMID: 39105117.","journal-title":"JACC Adv"},{"key":"9352_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s40119-022-00265-7","volume":"11","author":"CM Campbell","year":"2022","unstructured":"Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C, et al. Sex differences in wild-type transthyretin amyloidosis: an analysis from the transthyretin amyloidosis outcomes survey (THAOS). Cardiol Ther. 2022;11:393\u2013405 PMID: 35583798.","journal-title":"Cardiol Ther"},{"key":"9352_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/13506129.2023.2226298","volume":"30","author":"C Treitz","year":"2023","unstructured":"Treitz C, M\u00fcller-Marienburg N, Meli\u00df RR, Urban P, Axmann HD, Siebert F, et al. ATTR- and AFib amyloid - two different types of amyloid in the annular ligament of trigger finger. Amyloid. 2023;30:394\u2013406 PMID: 37353960.","journal-title":"Amyloid"},{"key":"9352_CR33","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.3390\/jcm13154328","volume":"13","author":"MDC Navarro-Saez","year":"2024","unstructured":"Navarro-Saez MDC, Feijoo-Mass\u00f3 C, S\u00e1nchez AB, Parente TP, Toran LG, Marcano-Fern\u00e1ndez FA, et al. Early diagnosis of amyloidosis and cardiac involvement through carpal tunnel surgery and predictive factors. J Clin Med. 2024;13:4328 PMID: 39124595.","journal-title":"J Clin Med"},{"key":"9352_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/13506129.2024.2398446","volume":"31","author":"S Yun","year":"2024","unstructured":"Yun S, Palladini G, Anderson LJ, Cariou E, Wang R, Angeli FS, et al. International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction. Amyloid. 2024;31:291\u2013301 PMID: 39245873.","journal-title":"Amyloid"},{"key":"9352_CR35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1056\/NEJM199702133360703","volume":"336","author":"MS Maurer","year":"1997","unstructured":"Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med. 1997;336:466\u201373 PMID: 27386769.","journal-title":"N Engl J Med"},{"key":"9352_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.26034","volume":"57","author":"HH Schmidt","year":"2018","unstructured":"Schmidt HH, Waddington-Cruz M, Botteman MF, Carter JA, Chopra AS, Hopps M, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018;57:829\u201337 PMID: 29211930.","journal-title":"Muscle Nerve"},{"key":"9352_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.121.003356","volume":"14","author":"P Chandrashekar","year":"2021","unstructured":"Chandrashekar P, Alhuneafat L, Mannello M, Al-Rashdan L, Kim MM, Dungu J, et al. Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: a systematic review. Circ Genom Precis Med. 2021;14:e003356.","journal-title":"Circ Genom Precis Med"},{"key":"9352_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cardfail.2020.08.007","volume":"27","author":"J Batra","year":"2021","unstructured":"Batra J, Rosenblum H, Defilippis EM, Griffin JM, Saith SE, Gamino D, et al. Sex differences in the phenotype of transthyretin cardiac amyloidosis due to Val122Ile mutation: insights from noninvasive pressure-volume analysis. J Card Fail. 2021;27:67\u201374 PMID: 32829019.","journal-title":"J Card Fail"},{"key":"9352_CR39","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1002\/ejhf.2646","volume":"24","author":"RK Patel","year":"2022","unstructured":"Patel RK, Ioannou A, Razvi Y, Chacko L, Venneri L, Bandera F, et al. Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosis. Eur J Heart Fail. 2022;24:2355\u201363 PMID: 36575133.","journal-title":"Eur J Heart Fail"},{"key":"9352_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13023-023-02962-5","volume":"18","author":"L Gentile","year":"2023","unstructured":"Gentile L, Coelho T, Dispenzieri A, Concei\u00e7\u00e3o I, Waddington-Cruz M, Kristen A, et al. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Orphanet J Rare Dis. 2023;18:350.","journal-title":"Orphanet J Rare Dis"},{"key":"9352_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jchf.2021.05.005","volume":"9","author":"AG Caponetti","year":"2021","unstructured":"Caponetti AG, Rapezzi C, Gagliardi C, Milandri A, Dispenzieri A, Kristen AV, et al. Sex-related risk of cardiac involvement in hereditary transthyretin amyloidosis: insights from THAOS. JACC Heart Fail. 2021;9:736\u201346 PMID: 34391735.","journal-title":"JACC Heart Fail."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-09352-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09352-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:02:30Z","timestamp":1764655350000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-09352-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9352"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-09352-x","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local ethics committee of the University of Regensburg. All patients provided written informed consent. The study was performed in accordance with the Helsinki Declaration (file number: 21\u20132742-101).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1085"}}